Nanomedicine News

RSS

Joint Venture on Multifunctional Nanoparticles for Magnetic Hyperthermia and Indirect Radiation Therapy

NPL is one of the founders of a European project, launched last week, which aims to improve the knowledge of combined cancer therapies by pairing experienced scientists and young researchers from nanophysics, chemical science and medicine.

18 Nov 2014

Tekmira Licenses Lipid Nanoparticle Delivery Technology for Dicerna's PH1 Development Program

Tekmira Pharmaceuticals Corporation a leading developer of RNA interference (RNAi) therapeutics, today announces a licensing and collaboration agreement with Dicerna Pharmaceuticals, Inc. Tekmira has licensed its proprietary lipid nanoparticle (LNP) delivery technology for exclusive use in Dicerna's primary hyperoxaluria type 1 (PH1) development program.

18 Nov 2014

Researchers Chemically Disguise RNAi Drugs to Enter Cells

Small pieces of synthetic RNA trigger a RNA interference (RNAi) response that holds great therapeutic potential to treat a number of diseases, especially cancer and pandemic viruses. The problem is delivery -- it is extremely difficult to get RNAi drugs inside the cells in which they are needed. To overcome this hurdle, researchers at University of California, San Diego School of Medicine have developed a way to chemically disguise RNAi drugs so that they are able to enter cells. Once inside, cellular machinery converts these disguised drug precursors -- called siRNNs -- into active RNAi drugs. The technique will publish Nov. 17 in Nature Biotechnology.

18 Nov 2014

Genetic-Based NanoFlare Technology Can Detect Live Cancer Cells in the Bloodstream

Metastasis is bad news for cancer patients. Northwestern University scientists now have demonstrated a simple but powerful tool that can detect live cancer cells in the bloodstream, potentially long before the cells could settle somewhere in the body and form a dangerous tumor.

18 Nov 2014

Enrollment Begins for Phase 2 Clinical Trial of Novavax’ Seasonal Influenza VLP

Novavax, Inc., a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, today announced that enrollment has begun in a Phase 2 clinical trial of its recombinant quadrivalent seasonal influenza virus-like particle (VLP) vaccine candidate (Seasonal Influenza VLP).

From Novavax Inc. 18 Nov 2014

Student Research on Gold Nanostructures Wins Top Honors at Siemens Competition

Months of dedication and hard work in science, technology, engineering and mathematics (STEM) paid off tonight for three students named National Finalists in the Siemens Competition in Math, Science & Technology, the nation’s premier research competition for high school students.

17 Nov 2014

Johns Hopkins Greenberg Bladder Cancer Institute Awards Grant to Develop Nanoparticles to Deliver Chemotherapy Drugs

A urine-based test for early detection and monitoring of bladder cancer and a plan to develop nanoparticles to deliver chemotherapy drugs to bladder tissue are among the first round of projects awarded research grants by the Johns Hopkins Greenberg Bladder Cancer Institute.

17 Nov 2014

Researchers Synthesize Platelet-Like Nanoparticles that Can Do more than Clot Blood

Stanching the free flow of blood from an injury remains a holy grail of clinical medicine. Controlling blood flow is a primary concern and first line of defense for patients and medical staff in many situations, from traumatic injury to illness to surgery. If control is not established within the first few minutes of a hemorrhage, further treatment and healing are impossible.

14 Nov 2014

The Journal of Spinal Disorders & Techniques Highlights nanOss® Clinical Data Results

RTI Surgical Inc.™ (RTI), a leading global surgical implant company, announced that The Journal of Spinal Disorders & Techniques published a study online highlighting nanOss® clinical data results. NanOss is an advanced bone graft substitute that is composed of nano-structured hydroxyapatite granules and an open structured engineered collagen carrier.

13 Nov 2014

UAMS Researcher Awarded Grant to Investigate Photoswitchable Nanoparticles for Cancer Diagnosis

University of Arkansas for Medical Sciences (UAMS) researcher Vladimir Zharov, Ph.D., D.Sc., recently was awarded a $1.5 million R01 grant by the National Institutes of Health to investigate his diagnostic concept — “In vivo reading written in blood” — with new stimuli-responsive nanoparticles circulating in blood.

13 Nov 2014

Nanomedicine News

Joint Venture on Multifunctional Nanoparticles for Magnetic Hyperthermia and Indirect Radiation Therapy

Tekmira Licenses Lipid Nanoparticle Delivery Technology for Dicerna's PH1 Development Program

Researchers Chemically Disguise RNAi Drugs to Enter Cells

Genetic-Based NanoFlare Technology Can Detect Live Cancer Cells in the Bloodstream

Enrollment Begins for Phase 2 Clinical Trial of Novavax’ Seasonal Influenza VLP

Student Research on Gold Nanostructures Wins Top Honors at Siemens Competition

Johns Hopkins Greenberg Bladder Cancer Institute Awards Grant to Develop Nanoparticles to Deliver Chemotherapy Drugs

Researchers Synthesize Platelet-Like Nanoparticles that Can Do more than Clot Blood

The Journal of Spinal Disorders & Techniques Highlights nanOss® Clinical Data Results

UAMS Researcher Awarded Grant to Investigate Photoswitchable Nanoparticles for Cancer Diagnosis

Combining Nanofluids and Turbulators for Sustainable Energy

Enhancing Material Properties through Nanotube Encapsulation

Brain-Inspired Nano-Tech Promises New Era for Electronics

Breakthrough in 2D Material Growth Opens Doors to Cleaner Energy and Next-Generation Technology

Sustainable Carbon Nanomaterial Gii Set to Transform Energy Storage in Internet of Things Devices

Electrospinning and the Future of Nanotechnology

How Electrospinning is Shaping the Future of Nanotechnology

Conversations on AFM: Applications of BioAFM in Life Science

Sponsored Content

Characterization of Active Pharmaceutical Ingredients, Injectables, and Proteins

The Future of Wound Care: Why Nanofibers are Key to Accelerated Healing

The Evolution of Lipid Nanoparticles

How Emulsion Electrospinning is Transforming Materials